Search results for " LAB"

showing 10 items of 2393 documents

Sleep under exposure to high-frequency electromagnetic fields.

2004

The controversy about potential health hazards associated with the exposure to electromagnetic fields (EMF) has been recently stimulated by the increasing use of mobile telecommunication devices. Attention has focused here on non-thermal effects of low-level high-frequency radiation, which does not lead to a heating of tissue. Scientific literature on the effects of high-frequency EMFs on sleep is reviewed. The epidemiological studies provide no evidence that sleep disturbances are a relevant complaint under exposure to such fields. Recent sleep laboratory studies have revealed a number of slight effects. Despite their heterogeneity, there seems to be some consistency regarding a slight sle…

Pulmonary and Respiratory MedicineSleep Wake Disordersmedicine.medical_specialtyCommunicationHealth consequencesbusiness.industryPolysomnographySleep laboratoryCell MembraneElectroencephalographyEnvironmental ExposureAudiologySleep in non-human animalsHazardous SubstancesElectromagnetic FieldsNeurologyPhysiology (medical)medicineHumansNeurology (clinical)businessPsychologyAlpha powerSleep eegSleep medicine reviews
researchProduct

Eligibility for treatment with omalizumab in Italy and Germany.

2013

Summary Omalizumab is an add-on therapy for patients with uncontrolled severe allergic asthma. In Europe, patients must fulfil a number of additional criteria to become eligible for omalizumab therapy, creating a challenge for epidemiology studies to quantify the potential patient pool. Thus, and in the absence of robust data, the number of omalizumab-eligible patients has remained unclear. To assess eligible patient numbers, a chart-audit design approach was employed to measure epidemiology variables based on patient-level data. 770 patient charts were reviewed in designated towns in Germany and Italy, in collaboration with >200 primary care physicians (PCPs) and respiratory specialists (R…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyPediatricsReferralEpidemiologySevere asthmaAllergic asthmaEligibility DeterminationOmalizumabPrimary careOmalizumabAntibodies Monoclonal HumanizedSeverity of Illness IndexAntibodiesSampling StudiesDose-Response RelationshipProduct LabelGermanyEpidemiologyMonoclonalmedicinePrevalenceHumansNational levelAnti-Asthmatic AgentsHumanizedAnti-immunoglobulin EEligibilityDose-Response Relationship Drugbusiness.industryPatient SelectionAllergic asthmaImmunoglobulin EAsthmaAntibodies Anti-IdiotypicAnti-IdiotypicTreatment OutcomeItalyQuality of LifeBiological MarkersDrugbusinessBiomarkersmedicine.drugAllergic asthma; Anti-immunoglobulin E; Eligibility; Epidemiology; Anti-Asthmatic Agents; Antibodies Anti-Idiotypic; Antibodies Monoclonal Humanized; Asthma; Biological Markers; Dose-Response Relationship Drug; Eligibility Determination; Germany; Humans; Immunoglobulin E; Italy; Patient Selection; Prevalence; Quality of Life; Sampling Studies; Severity of Illness Index; Treatment OutcomeRespiratory medicine
researchProduct

Indacaterol/glycopyrronium/mometasone fixed dose combination for uncontrolled asthma

2021

INTRODUCTION Asthma symptoms can be relieved through a maintenance treatment combining long-acting β2-agonist and inhaled corticosteroids (LABA/ICS). However, for patients with inadequately controlled asthma, the LABA/ICS combination might not be sufficient. Under these conditions, clinical guidelines recommend the administration of inhaled long-acting muscarinic antagonists (LAMA) as an add-on therapy to LABA/ICS to better control asthma and improve lung function. For nearly two decades, the only LAMA to be approved on the market has been tiotropium. AREAS COVERED We reviewed recent clinical studies evaluating the safety and efficacy of LABA/LAMA/ICS fixed dose combinations by searching Pu…

Pulmonary and Respiratory Medicinemedicine.medical_specialtycorticosteroidFixed-dose combinationLABAAsthma corticosteroid fixed dose combination ICS inhaler LABA LAMA once daily combination uncontrolled asthmaMuscarinic Antagonistsonce daily combinationQuinolonesSettore MED/10 - Malattie Dell'Apparato RespiratorioinhalerAdrenal Cortex HormonesInternal medicineAdministration InhalationImmunology and AllergyMedicineHumansfixed dose combinationAdrenergic beta-2 Receptor AgonistsAsthmaFluticasonebiologyInhalationuncontrolled asthmabusiness.industryInhalerPublic Health Environmental and Occupational HealthLAMALamamedicine.diseasebiology.organism_classificationGlycopyrrolateFluticasone-Salmeterol Drug CombinationAsthmarespiratory tract diseasesDrug CombinationsICSIndansIndacaterolSalmeterolbusinessMometasone Furoatehormones hormone substitutes and hormone antagonistsmedicine.drug
researchProduct

Rho protein inactivation induced apoptosis of cultured human endothelial cells.

2002

Small GTP-binding Rho GTPases regulate important signaling pathways in endothelial cells, but little is known about their role in endothelial cell apoptosis. Clostridial cytotoxins specifically inactivate GTPases by glucosylation [ Clostridium difficile toxin B-10463 (TcdB-10463), C. difficile toxin B-1470 (TcdB-1470)] or ADP ribosylation ( C. botulinum C3 toxin). Exposure of human umbilical cord vein endothelial cells (HUVEC) to TcdB-10463, which inhibits RhoA/Rac1/Cdc42, or to C3 toxin, which inhibits RhoA, -B, -C, resulted in apoptosis, whereas inactivation of Rac1/Cdc42 with TcdB-1470 was without effect, suggesting that Rho inhibition was responsible for endothelial apoptosis. Disruptio…

Pulmonary and Respiratory Medicinerac1 GTP-Binding Proteinrho GTP-Binding ProteinsProgrammed cell deathUmbilical VeinsEndotheliumPhysiologyBacterial ToxinsCASP8 and FADD-Like Apoptosis Regulating ProteinApoptosisBcl-2-associated X proteinBacterial ProteinsPhysiology (medical)Proto-Oncogene ProteinsmedicineCyclic AMPIn Situ Nick-End LabelingHumanscdc42 GTP-Binding ProteinCells Culturedbcl-2-Associated X ProteinAdenosine Diphosphate RibosebiologyCaspase 3Intracellular Signaling Peptides and ProteinsCell BiologyCaspase 9Cell biologyNeoplasm ProteinsEndothelial stem cellmedicine.anatomical_structureCdc42 GTP-Binding ProteinProto-Oncogene Proteins c-bcl-2Cell cultureApoptosisCaspasesbiology.proteinMyeloid Cell Leukemia Sequence 1 ProteinEndothelium VascularSignal transductionCarrier ProteinsrhoA GTP-Binding ProteinBH3 Interacting Domain Death Agonist ProteinSignal TransductionAmerican journal of physiology. Lung cellular and molecular physiology
researchProduct

Standardization of reagents and methods used in cytological and histological practice with emphasis on dyes, stains and chromogenic reagents

1994

The need for the standardization of reagents and methods used in the histology laboratory is demonstrated. After definitions of dyes, stains, and chromogenic reagents, existing standards and standards organizations are discussed. This is followed by practical instructions on how to standardize dyes and stains through the preparation of reference materials and the development of chromatographic methods. An overview is presented of the problems concerned with standardization of the Romanowsky-Giemsa stain for cytological and histological application. Finally, the problem of how to convince routine dye and stain users of the need for standardization in their histology laboratories is discussed.

Quality ControlChromatographyStaining and LabelingStandardizationChemistryChromogenicCytological TechniquesHistological TechniquesCell BiologyReference StandardsStainStainingInvestigation methodsChromogenic CompoundsAnimalsHumansAnatomyColoring AgentsReference standardsThe Histochemical Journal
researchProduct

Improving Biological Dyes and Stains: Quality Testing Versus Standardization

1994

This paper discusses the impact of both standardization and quality testing of dyes and stains in biology and medicine. After the brief review of why standardized dyes and strains are not presently available commercially, two types of testing and ways of improving dye quality are described. National or international organizations could be established to define standardization of dyes and stains. Standardization would be specifically defined as a list of physico-chemical parameters such as elaborated in this paper. Commercial batches of comparable quality may be labeled by the supplier as "standard dye," a procedure currently performed by the European Council for Clinical and Laboratory Stan…

Quality ControlHistologyStaining and LabelingStandardizationHistocytochemistrybusiness.industrymedia_common.quotation_subjectColoring agentsGeneral MedicineCertificationManufacturing engineeringEuropeMedical Laboratory TechnologyBiological stainTesting protocolsHumansMedicineQuality (business)Coloring AgentsDye testingbusinessmedia_commonBiotechnic & Histochemistry
researchProduct

Cryopreservation of MHC Multimers: Recommendations for Quality Assurance in Detection of Antigen Specific T Cells

2015

Fluorescence-labeled peptide-MHC class I multimers serve as ideal tools for the detection of antigen-specific T cells by flow cytometry, enabling functional and phenotypical characterization of specific T cells at the single cell level. While this technique offers a number of unique advantages, MHC multimer reagents can be difficult to handle in terms of stability and quality assurance. The stability of a given fluorescence-labeled MHC multimer complex depends on both the stability of the peptide-MHC complex itself and the stability of the fluorochrome. Consequently, stability is difficult to predict and long-term storage is generally not recommended. We investigated here the possibility of…

Quality ControlHistologyT-LymphocytesSerum albuminquality assuranceBiologyrecommendations for MHC multimer storageMajor histocompatibility complexcryopreservationEpitopeCryopreservationPathology and Forensic MedicineFlow cytometryCryoprotective AgentsAntigen specificQuantum DotsmedicineHumansFluorescent Dyesmedicine.diagnostic_testStaining and LabelingcryoprotectantHistocompatibility Antigens Class IReproducibility of ResultsCell BiologyMHC multimerFlow CytometryMolecular biologyMHC multimerBiochemistrybiology.proteinSpecial Section : Improving Methods for Blood Cell AnalysisIndicators and Reagentsglycerol in T cell stainingProtein MultimerizationPeptidesCytometry
researchProduct

The EDNAP mitochondrial DNA population database (EMPOP) collaborative exercises: organisation, results and perspectives.

2003

This paper presents an overview of the organisation and the results of the collaborative exercises (CE) of the European DNA Profiling (EDNAP) Group's mitochondrial DNA population database project (EMPOP). The aim of the collaborative exercises was to determine whether uniformity of mtDNA sequencing results could be achieved among different laboratories. These were asked to sequence either the complete mtDNA control region or the two hypervariable regions HVI (16024-16365) and HVII (73-340) from DNA extracts, buccal swabs or bloodstains, proceeding in accordance with the protocol and strategies used in each individual laboratory. The results of the collaborative exercises were employed to id…

Quality ControlMitochondrial DNAPopulationContext (language use)Biologycomputer.software_genreDNA MitochondrialPolymerase Chain ReactionPathology and Forensic MedicinePopulation DatabaseHumansCooperative BehavioreducationDNA PrimersmtDNA control regionGeneticsProtocol (science)education.field_of_studybusiness.industryClinical Laboratory TechniquesSequence Analysis DNAForensic MedicineHypervariable regionGenetics PopulationDNA profilingArtificial intelligencebusinessDatabases Nucleic AcidLawcomputerNatural language processingForensic science international
researchProduct

Paternity Testing Commission of the International Society of Forensic Genetics: recommendations on genetic investigations in paternity cases

2003

The International Society for Forensic Genetics (ISFG) has established a Paternity Testing Commission (PTC) with the purpose of formulating international recommendations concerning genetic investigations in paternity testing. The PTC recommends that paternity testing be performed in accordance with the ISO 17025 standards. The ISO 17025 standards are general standards for testing laboratories and the PTC offers explanations and recommendations concerning selected areas of special importance to paternity testing. # 2002 Elsevier Science Ireland Ltd. All rights reserved.

Quality Controlendocrine system diseasesClinical Laboratory Techniquesbusiness.industryInternational CooperationPaternityMedical lawCommissionDNA FingerprintingPolymerase Chain ReactionPathology and Forensic MedicineEquipment and SuppliesPolitical scienceForensic engineeringHumansMedicineEngineering ethicsForms and Records ControlLaboratoriesbusinessLawForensic geneticsForensic Science International
researchProduct

The Social Exclusion Bench Tool (SEBT): A visual way of assessing interpersonal social exclusion

2021

People usually prefer to appear with an inclusive and positive attitude to others’ eyes. For this reason, the self-report scales assessing social exclusion intentions are often biased by social desirability. In this work, we present an innovative graphical tool, named Social Exclusion Bench Tool (SEBT), for assessing social exclusion not influenced by social desirability. The tool is based on the consistency between social distance and physical distance evaluation. The results showed that in two samples of adults from Italy (N = 252) and the UK (N = 254), the SEBT positively correlated with self-report measures of social exclusion, but not with the social desirability measure. The tool has …

QualtricsHeat mapSocial exclusionScienceSocial distanceQClinical BiochemistryQualtricSocial desirabilityContext (language use)Interpersonal communicationMethod ArticleSocial Exclusion Bench Tool (SEBT)Social groupMedical Laboratory TechnologyConsistency (negotiation)Social exclusionPositive attitudePsychologyGraphic toolSocial psychologySocial desirability
researchProduct